Cutigen Research Institute

Cutigen Research Institute is a South Korean biotechnology company specializing in regenerative medicine and advanced cell therapies, primarily focused on skin and musculoskeletal repair. As the research arm of Tegoscience, the institute developed Kaloderm, a leading allogeneic keratinocyte-derived skin substitute used for treating burns and diabetic foot ulcers. Their pipeline extends beyond dermatology into orthopedics and ophthalmology, utilizing proprietary cell culture platforms to develop treatments for rotator cuff tears and corneal damage. The company is a pioneer in the Korean cell therapy market, maintaining a robust portfolio of autologous and allogeneic products that address significant unmet needs in wound healing and tissue regeneration.